Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review.
about
The evolving role of response-adapted PET imaging in Hodgkin lymphomaPhotoacoustic Imaging of Cancer Treatment Response: Early Detection of Therapeutic Effect from Thermosensitive Liposomes18F-FDG PET/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretation.The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scaleA functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphoma.Hodgkin's lymphoma therapy: past, present, and future.Fluorine-18-fluorodeoxyglucose positron emission tomography in response assessment before high-dose chemotherapy for lymphoma: a systematic review and meta-analysis.Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and CaveatsUtilisation of search filters in systematic reviews of prognosis questions.Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography.Positron Emission Tomography (PET) in OncologyPrognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era.The Management of Classical Hodgkin's Lymphoma: Past, Present, and FuturePredictive value of interim PET/CT in DLBCL treated with R-CHOP: meta-analysisThe role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphomaPrognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma.Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma.Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma.Colorectal lymphoma.Imaging in childhood cancer: a Society for Pediatric Radiology and Children's Oncology Group Joint Task Force reportFDG-PET/CT based response-adapted treatment.Positron emission tomographic scans in lymphoma: convention and controversy.Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404)A pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy.State-of-the-Art Research on "Lymphomas: Role of Molecular Imaging for Staging, Prognostic Evaluation, and Treatment Response".Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma.ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma.FDG PET/CT response in diffuse large B-cell lymphoma: Reader variability and association with clinical outcome.Current clinical evidence on interim fluorine-18 fluorodeoxy glucose positron emission tomography for advanced-stage Hodgkin lymphoma and diffuse large B-cell lymphoma to predict treatment outcomes.The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma.Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses.PET Response-Guided Treatment of Hodgkin's Lymphoma: A Review of the Evidence and Active Clinical TrialsConvergence technology in cancer medicine.Report of satellite workshop on interim-PET in Hodgkin lymphoma: 8th International Symposium on Hodgkin Lymphoma, Cologne, 23 October 2010.Early interim PET scans in diffuse large B-cell lymphoma: can there be consensus about standardized reporting, and can PET scans guide therapy choices?Advances in oncologic imaging: update on 5 common cancers.Renewed interest in the role of consolidative radiotherapy in advanced stage diffuse large B-cell lymphoma.The use of interim (18)F-fluorodeoxyglucose PET to guide therapy in lymphoma.
P2860
Q26750993-C35E3B56-ADDF-4493-8FEC-E75E9A7E49DBQ28553001-60B7DFEC-D875-4F5E-B1E1-1460C0FF3260Q33606294-E21C4B4F-B069-4FA5-865B-E0B1E7AD0707Q33696003-FA1FCB63-E792-41D1-B96C-E4889919EEC1Q33952842-2AEC3EE4-96BF-4FC3-977B-4945AE90D3D1Q34296914-100C4B73-6AAC-4D7F-B97D-D9BFDEE21B6FQ34355722-BAAFD50B-AC20-4FE9-805E-805163247CADQ34475763-127B589C-5971-4B78-9611-4E4A9749A32AQ34486542-99A5AAE5-D546-41DB-B803-02716E85178AQ34495333-C543A200-D20F-462E-ADCA-899BF00177A6Q34774840-A0725A61-4F8F-4801-8309-EAF25565C24EQ34882773-51034530-10B5-4959-A02A-A4FCC9AF984CQ35038852-AC8273C2-3E47-45D9-AF76-8BD618FF3A0EQ35091121-9BA0E29F-766C-4546-B1EF-C80DD0F2B5F8Q35152064-4CBB5773-C6A9-4AC2-8E34-857382677AD6Q35232775-7739E23F-9D1F-4643-AB7A-EEC073E8EC29Q35439403-D37C882C-9657-48EE-B79A-7B2CDD8FA245Q35723986-E5C44B93-6595-4328-8BF7-64047EFA087DQ35794450-6BF1E61E-4DE7-42D7-AC25-EC7C7F3FF506Q35850171-5311F1AE-8DF6-4A20-87CA-927E9172FAADQ36257743-9B4E0D43-DCBA-4BB3-BCA6-267550962DA3Q36286595-D15F0900-4707-4F58-A6E2-26E2534B5341Q36399538-38560D41-D881-4EE7-AC9C-785AA2F60C5EQ36417808-EB4F19A9-8DCC-4BE2-A439-62BD17C86DB4Q36816955-2B5483B9-A513-421F-A4DD-55936705E98EQ37144956-C587D567-476C-4F5D-A4A4-B8E49AB2BBDFQ37240835-19F0CA33-6B65-419B-B1E6-7E0C7B055B4CQ37561054-59F422EE-427F-417E-9AA0-2DB45B16A61BQ37598106-C485651B-0AA2-4439-8B8C-D5635D1264B7Q37605897-1D7E3B9A-C48B-47B8-A93A-3ADDDCE1AFF6Q37622870-46CCA376-E335-4E9E-923A-91144FF973B1Q37641042-4673E9B8-D061-4EF4-9C20-3DFA302A8FCCQ37821961-EBF89A51-7FA2-4A29-A5EE-8204078EB087Q37828408-211CC0E2-CB63-4AAF-B5EE-71CA9D54A0DCQ37850452-ECEDA9A1-3506-4553-8CAB-23250E94BB95Q37857870-609E834A-0429-4C06-A29C-694E5FEAD7ABQ38020791-D5C6031C-0DFC-4ABB-98C7-C73E59EF2C9AQ38052458-6E014364-7596-49EA-8DD5-4C244E0D2806Q38085077-AD1DA3DB-6A43-48CD-AAAC-FDF8B96FCE9FQ38110318-04882329-635A-4772-B872-EEB427432B50
P2860
Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fluorine-18-fluorodeoxyglucose ...... lymphoma: a systematic review.
@en
Fluorine-18-fluorodeoxyglucose ...... lymphoma: a systematic review.
@nl
type
label
Fluorine-18-fluorodeoxyglucose ...... lymphoma: a systematic review.
@en
Fluorine-18-fluorodeoxyglucose ...... lymphoma: a systematic review.
@nl
prefLabel
Fluorine-18-fluorodeoxyglucose ...... lymphoma: a systematic review.
@en
Fluorine-18-fluorodeoxyglucose ...... lymphoma: a systematic review.
@nl
P2093
P356
P1476
Fluorine-18-fluorodeoxyglucose ...... lymphoma: a systematic review.
@en
P2093
Hirokazu Nagai
Joseph Lau
Martin Hutchings
Olivier Couturier
Stéphane Bardet
Takashi Nihashi
Teruhiko Terasawa
Tomomitsu Hotta
P304
P356
10.1200/JCO.2008.16.0861
P407
P577
2009-03-09T00:00:00Z